GSK plans to sell off remaining stake in consumer spinout Haleon
British drugmaker GSK will sell off the rest of its share in Haleon after slowly selling off multibillion-dollar pieces of its ownership in the consumer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.